DrugWAS: Drug-wide association studies for COVID-19 drug repurposing
In conclusion, this cohort study leveraged EHR data to identify a list of drugs that could be repurposed to improve COVID-19 outcomes. Further randomized clinical trials are needed to investigate the efficacy of the proposed drugs.PMID:34314511 | DOI:10.1002/cpt.2376
Source: Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Cosmin A Bejan Katherine N Cahill Patrick J Staso Leena Choi Josh F Peterson Elizabeth J Phillips Source Type: research
More News: Astelin | Clinical Trials | COVID-19 | Diphtheria | Drugs & Pharmacology | Electronic Health Records (EHR) | Estradiol | Flaxseed | Flonase | Ibuprofen | Intensive Care | Meningitis Vaccine | Omega 3 | Pandemics | Pneomococcal Vaccine | Study | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Turmeric | Vaccines | Whooping Cough (Pertussis) Vaccine
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024